TNF Pharmaceuticals Inc. Expands into Cryptocurrency with Exclusive Global Rights to Light-Based Computing Technology
Reuters
Sep 02
TNF Pharmaceuticals Inc. Expands into Cryptocurrency with Exclusive Global Rights to Light-Based Computing Technology
TNF Pharmaceuticals Inc. has announced a significant expansion into the technology sector by securing exclusive global rights to an innovative light-based computing accelerator for cryptocurrency applications. The company's new strategic partnership with LightSolver Ltd. aims to deploy the first laser-based processing unit, which is expected to outperform traditional computing systems, including quantum and supercomputing. This move positions TNF as a first mover in the burgeoning photonic computing and cryptocurrency infrastructure markets. As part of this expansion, TNF is also planning to change its corporate name to reflect its new direction. The company has secured a $7.0 million private placement financing deal, involving key stockholders, to support this venture. TNF is in advanced discussions to enhance its development and commercialization strategy for this cutting-edge technology.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. TNF Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001641172-25-026167), on September 02, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.